CN Stock MarketDetailed Quotes
600223 Lushang Freda Pharmaceutical
- 8.21
- -0.49-5.63%
Market Closed May 23 15:00 CST
8.35BMarket Cap35.85P/E (TTM)
8.54High8.12Low280.10KlotVolume8.41Open8.70Pre Close231.83MTurnover2.76%Turnover Ratio27.55P/E (Static)1.02BShares11.5552wk High2.05P/B8.35BFloat Cap6.3852wk Low9.57Limit Up1.02BShs Float18.79Historical High7.83Limit Down4.83%Amplitude1.47Historical Low--Dividend TTM8.28Avg Price170.35KlotAsk--Div YieldTTM100Lot Size107.10KlotBid
Lushang Freda Pharmaceutical Key Stats
All
YOY
| (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | (FY)Dec 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | -46.75%889.57M | -40.55%5.8B | -52.86%3.69B | -49.09%3.05B | -9.67%1.67B | -43.49%9.75B | -39.15%7.82B | -35.96%6B | -48.22%1.85B | 4.07%17.26B |
| Refunds of taxes and levies | 230.37%4.11M | -60.80%4.81M | -61.26%3.95M | -67.48%2.29M | -78.14%1.24M | 54.23%12.26M | -18.82%10.2M | 13.76%7.03M | 173.32%5.69M | 14.58%7.95M |
| Cash received relating to other operating activities | -16.60%36.42M | -78.85%229.15M | -74.62%309.08M | -89.99%84.5M | -88.87%43.67M | -23.30%1.08B | -7.86%1.22B | 11.72%844.01M | 33.55%392.43M | 0.86%1.41B |
| Cash inflows from operating activities | -45.78%930.1M | -44.40%6.03B | -55.80%4B | -54.15%3.14B | -23.68%1.72B | -41.92%10.85B | -36.22%9.05B | -32.37%6.85B | -41.89%2.25B | 3.82%18.68B |
| Goods services cash paid | -44.20%391.98M | -55.52%2.78B | -65.23%1.79B | -68.17%1.38B | -61.06%702.49M | -14.62%6.24B | -14.06%5.14B | 1.13%4.35B | -32.26%1.8B | -28.16%7.31B |
| Staff behalf paid | -26.21%116.22M | -21.62%538.21M | -16.44%417.79M | -22.71%259.04M | -9.58%157.49M | -4.11%686.7M | -2.63%499.99M | -8.76%335.18M | -17.24%174.18M | 36.66%716.1M |
| All taxes paid | -82.25%52.71M | -49.80%557.99M | -48.45%462.91M | -33.03%405.18M | -23.97%296.97M | -38.02%1.11B | -40.41%897.94M | -43.44%605.03M | -31.25%390.6M | 33.21%1.79B |
| Cash paid relating to other operating activities | -28.60%331.32M | -6.96%1.69B | -22.00%1.01B | 26.77%851.73M | 103.14%464.02M | -9.99%1.81B | -7.40%1.29B | -29.03%671.87M | 28.94%228.42M | 34.25%2.01B |
| Cash outflows from operating activities | -44.96%892.24M | -43.58%5.56B | -53.05%3.67B | -51.35%2.9B | -37.59%1.62B | -16.74%9.85B | -16.67%7.82B | -10.82%5.96B | -28.23%2.6B | -12.64%11.83B |
| Net cash flows from operating activities | -59.91%37.86M | -52.49%474.15M | -73.30%327.92M | -72.95%240.3M | 127.00%94.45M | -85.43%998.1M | -74.43%1.23B | -74.20%888.42M | -240.73%-349.84M | 53.96%6.85B |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | -28.89%6.4M | 2,463.03%47.98M | 1,387.73%24.86M | 702.85%9M | 702.85%9M | -92.38%1.87M | -84.40%1.67M | -60.75%1.12M | -52.42%1.12M | -41.47%24.58M |
| Cash received from returns on investments | -56.68%115.2K | -52.08%62.69M | -24.76%62.69M | -92.06%434.56K | -95.14%265.93K | 103.19%130.81M | 30.79%83.32M | 12,509.61%5.48M | 15,412.06%5.48M | 52.29%64.38M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | --138.72K | -31.80%3.89M | -92.74%927.48K | -84.02%927.48K | ---- | 835.03%5.7M | 2,275.30%12.78M | 2,488.61%5.81M | 164.98%144.85K | 4.85%610.03K |
| Net cash received from disposal of subsidiaries and other business units | 113.82%2.95B | --2.64B | --1.38B | --1.38B | --1.38B | ---- | ---- | ---- | ---- | --33.05M |
| Cash received relating to other investing activities | 1,034.56%83.87M | -25.75%149.81M | -80.13%9.37M | -78.57%9.37M | -50.72%7.39M | -49.27%201.76M | 60.89%47.18M | 140.29%43.73M | --15M | -44.79%397.73M |
| Cash inflows from investing activities | 117.76%3.04B | 754.00%2.9B | 919.51%1.48B | 2,393.73%1.4B | 6,323.65%1.4B | -34.63%340.15M | 5.56%144.95M | 3.24%56.13M | 788.85%21.74M | -35.38%520.35M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -13.20%41.47M | 27.24%211.37M | 52.51%170.96M | 157.22%163.85M | 40.09%47.78M | -41.00%166.11M | -41.23%112.1M | -59.07%63.7M | -4.90%34.11M | 79.24%281.53M |
| Cash paid to acquire investments | ---- | -98.26%1.62M | -68.32%14.42M | -91.16%3.81M | -96.24%1.62M | -25.70%92.93M | -61.95%45.53M | -61.42%43.13M | --43.13M | 116.71%125.08M |
| Cash paid relating to other investing activities | ---- | -76.66%18.64M | -92.61%5.84M | -90.64%5.84M | -85.14%4M | -85.88%79.87M | -21.14%78.98M | 141.40%62.39M | 4.17%26.92M | 117.71%565.55M |
| Cash outflows from investing activities | -22.34%41.47M | -31.66%231.63M | -19.18%191.23M | 2.54%173.51M | -48.73%53.4M | -65.14%338.92M | -42.37%236.6M | -42.30%169.22M | 68.78%104.16M | 36.92%972.16M |
| Net cash flows from investing activities | 123.33%3B | 216,131.58%2.67B | 1,503.67%1.29B | 1,184.21%1.23B | 1,729.72%1.34B | 100.27%1.24M | 66.45%-91.65M | 52.66%-113.09M | -39.07%-82.42M | -574.46%-451.81M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | ---- | -97.84%3.2M | -97.61%3.2M | ---- | ---- | -81.51%147.9M | 430,850.88%133.68M | 3,059.25%980K | --980K | -42.67%800.08M |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | ---- | -97.45%3.2M | -97.57%3.2M | ---- | ---- | -83.98%125.44M | 424,842.62%131.82M | 3,059.25%980K | --980K | 65.42%783.03M |
| Cash from borrowing | -88.70%57M | -61.22%1.69B | -74.89%958M | -74.47%821M | -39.41%504.25M | -21.70%4.36B | 24.66%3.82B | 42.34%3.22B | 6.16%832.2M | -37.87%5.57B |
| Cash received relating to other financing activities | ---- | -87.78%1.01B | -84.55%896.28M | -75.90%847.4M | -42.94%821.31M | 89.44%8.26B | 261.74%5.8B | 216.02%3.52B | 119.88%1.44B | -25.74%4.36B |
| Cash inflows from financing activities | -95.70%57M | -78.82%2.7B | -80.95%1.86B | -75.22%1.67B | -41.67%1.33B | 18.99%12.77B | 109.03%9.75B | 99.68%6.73B | 57.98%2.27B | -33.89%10.73B |
| Borrowing repayment | 368.68%1.57B | -27.59%4.37B | -57.80%2.34B | -40.92%2.15B | -72.12%335.29M | -22.22%6.04B | 39.00%5.56B | 3.61%3.64B | 16.29%1.2B | -5.40%7.77B |
| Dividend interest payment | -90.65%19.66M | -57.23%515.88M | -55.87%415.56M | -58.02%297.15M | -7.09%210.19M | -41.07%1.21B | -29.54%941.67M | -27.65%707.78M | -50.76%226.24M | -11.03%2.05B |
| -Including:Cash payments for dividends or profit to minority shareholders | ---- | -9.91%27.93M | -21.64%24.29M | 51.83%24.29M | --292.03K | -0.79%31M | --31M | --16M | ---- | -7.40%31.25M |
| Cash payments relating to other financing activities | -99.98%140.61K | -87.22%912.36M | -79.29%990.01M | -73.97%757.42M | 51.50%710.39M | -7.37%7.14B | -0.10%4.78B | 20.56%2.91B | -62.13%468.89M | -16.89%7.71B |
| Cash outflows from financing activities | 26.71%1.59B | -59.67%5.8B | -66.75%3.75B | -55.83%3.21B | -33.82%1.26B | -17.89%14.39B | 11.46%11.28B | 5.10%7.26B | -30.54%1.9B | -11.44%17.52B |
| Net cash flows from financing activities | -2,301.45%-1.53B | -91.47%-3.1B | -23.67%-1.89B | -191.41%-1.54B | -81.42%69.69M | 76.17%-1.62B | 71.95%-1.53B | 85.07%-528.02M | 129.00%375.03M | -91.20%-6.79B |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | 100.42%4.48K | -110.25%-1.01M | -163.69%-600.95K | -253.75%-705.35K | -22,826.00%-1.07M | 2,502.43%9.82M | 4,960.48%943.6K | 333.48%458.76K | 124.22%4.7K | 73.49%-408.93K |
| Net increase in cash and cash equivalents | -0.20%1.5B | 108.04%48.93M | 29.01%-279.08M | -129.45%-72.98M | 2,732.64%1.51B | -54.77%-608.61M | 57.52%-393.12M | 174.65%247.77M | 94.82%-57.21M | -139.69%-393.24M |
| Add:Begin period cash and cash equivalents | 2.99%1.69B | -27.09%1.64B | -27.09%1.64B | -27.09%1.64B | -27.09%1.64B | -14.89%2.25B | -14.89%2.25B | -14.89%2.25B | -14.89%2.25B | 60.08%2.64B |
| End period cash equivalent | 1.46%3.19B | 2.99%1.69B | -26.68%1.36B | -37.25%1.57B | 43.61%3.14B | -27.09%1.64B | 8.11%1.85B | 8.08%2.49B | 42.53%2.19B | -14.89%2.25B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | Shanghui Certified Public Accountants (Special General Partnership) | -- | -- | -- | Shanghui Certified Public Accountants (Special General Partnership) | -- | -- | -- | Daishin Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
CN
Overall
Symbol
Latest Price
%Chg